TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EXEL

Exelixis Inc

Healthcare · Biotechnology

58.40$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement EXEL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+48.0% +415.0% +136.3% +88.7% +13.3% +2.0% +45.3% +12.3% +13.6% +18.5% +7.0%
+90.7% +68.2% +129.9% +74.9% +25.6% +9.6% +45.8% +9.5% +25.3% +5.1% +9.8%
+44.3% +455.6% +136.6% +89.2% +13.0% +1.8% +45.3% +12.4% +13.2% +19.0% +6.9%
-49.0% -0.4% +16.9% +62.5% +84.9% +62.6% +26.6% +28.6% +17.1% -12.8% -9.4%
+12.7% +102.7% +37.2% +29.5% +10.6% +28.5% +36.9% +14.5% +9.3% -2.1% -5.1%
-36.0% +38.0% +28.0% +43.1% +45.4% +48.8% +30.2% +23.4% +17.4% -6.2% -8.3%
+164.5% -15.8% -70.2% +160.5% -29.7% -15.2% +253.8% +44.3%
-1.6% -18.7% -73.7% -100.0%
+185.1% -11.9% -67.1% +124.8% -20.3% +9.9% +164.7% +38.1%
+58,187.3% -86.4% -5,570.8% -75.3% +231.1% -17.5% -4.4% +222.3% -1.1%
+347.4% -53.5% -65.2% +106.7% -21.1% +14.0% +150.9% +50.1%
+170.4% -16.4% -68.5% +151.9% -26.0% +27.4% +153.8% +28.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?